Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Trigeminal Nerve/drug effects"'
Publikováno v:
Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-LaryngologyCervico-Facial SurgeryREFERENCES. 46(6)
Objective: The aim of the study was to determine the relationship between nasal nitric oxide (nNO) and olfactory sensitivity, trigeminal sensitivity and nasal airflow in healthy subjects. Study design: This is a correlational study. Setting: This stu
Publikováno v:
Scientific Reports
Scientific Reports, Vol 8, Iss 1, Pp 1-13 (2018)
Munro, G, Petersen, S, Jansen-Olesen, I & Olesen, J 2018, ' A unique inbred rat strain with sustained cephalic hypersensitivity as a model of chronic migraine-like pain ', Scientific Reports, vol. 8, 1836 . https://doi.org/10.1038/s41598-018-19901-1
Scientific Reports, Vol 8, Iss 1, Pp 1-13 (2018)
Munro, G, Petersen, S, Jansen-Olesen, I & Olesen, J 2018, ' A unique inbred rat strain with sustained cephalic hypersensitivity as a model of chronic migraine-like pain ', Scientific Reports, vol. 8, 1836 . https://doi.org/10.1038/s41598-018-19901-1
Animal models of migraine-like pain enabling ongoing study of behaviour typically involve the systemic administration of chemical vasodilators or dural administration of inflammatory algogens. However, neither method mediates prolonged effects on beh
Autor:
Mark Obermann, Giulia Di Stefano, Lars Bendtsen, Valerie Morisset, Deb Steiner, Stine Maarbjerg, Joanne Palmer, Joanna M Zakrzewska, Giorgio Cruccu, Simon Tate, Dominik A Ettlin
Publikováno v:
Zakrzewska, J M, Palmer, J, Bendtsen, L, Di Stefano, G, Ettlin, D A, Maarbjerg, S, Obermann, M, Morisset, V, Steiner, D, Tate, S & Cruccu, G 2018, ' Challenges recruiting to a proof-of-concept pharmaceutical trial for a rare disease : the trigeminal neuralgia experience ', Trials, vol. 19, 704 . https://doi.org/10.1186/s13063-018-3045-1
Trials
Trials, Vol 19, Iss 1, Pp 1-10 (2018)
Trials
Trials, Vol 19, Iss 1, Pp 1-10 (2018)
BACKGROUND: This study aimed to describe recruitment challenges encountered during a phase IIa study of vixotrigine, a state and use-dependent Nav1.7 channel blocker, in individuals with trigeminal neuralgia.METHODS: This was an international, multic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7eb93473659684d343d388d0577c2a9b
http://hdl.handle.net/11573/1233672
http://hdl.handle.net/11573/1233672